AEON Biopharma, Inc. (AEON)
(Delayed Data from AMEX)
$1.68 USD
-0.05 (-2.89%)
Updated May 13, 2024 04:00 PM ET
After-Market: $1.67 -0.01 (-0.60%) 5:12 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for AEON Biopharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -36.63 | 9.98 | 8.20 | 0.00 | NA |
Depreciation/Amortization & Depletion | 0.10 | 0.00 | 0.00 | 0.00 | NA |
Net Change from Assets/Liabilities | -2.74 | 3.23 | 0.44 | 0.00 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | -8.55 | -14.19 | -10.14 | 0.00 | NA |
Net Cash From Operating Activities | -47.83 | -0.98 | -1.49 | 0.00 | NA |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.40 | -276.00 | 0.00 | NA |
Net Cash from Investing Activities | 0.00 | 0.40 | -276.00 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 278.30 | 0.00 | NA |
Issuance (Repayment) of Debt | 14.00 | 0.15 | -0.04 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | -0.27 | 0.00 | NA |
Net Cash from Financing Activities | 14.00 | 0.15 | 277.99 | 0.00 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -33.83 | -0.43 | 0.50 | 0.00 | NA |
Cash at Beginning of Period | 40.98 | 0.50 | 0.00 | 0.00 | NA |
Cash at End of Period | 7.16 | 0.07 | 0.50 | 0.00 | NA |
Diluted Net EPS | -0.99 | 0.29 | 0.26 | NA | NA |
Fiscal Year End for AEON Biopharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -36.63 | 5.86 | -4.33 | -0.39 |
Depreciation/Amortization & Depletion | NA | 0.10 | 0.08 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | NA | -2.74 | -1.29 | 4.20 | 1.52 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -8.55 | -41.45 | -1.44 | -1.76 |
Net Cash From Operating Activities | NA | -47.83 | -36.81 | -1.57 | -0.62 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 260.09 | 260.01 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 260.09 | 260.01 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | -259.00 | -259.00 |
Issuance (Repayment) of Debt | NA | 14.00 | 14.00 | 0.85 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 14.00 | 14.00 | -258.15 | -259.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -33.83 | -22.81 | 0.37 | 0.39 |
Cash at Beginning of Period | NA | 40.98 | 40.98 | 0.07 | 0.07 |
Cash at End of Period | NA | 7.16 | 18.18 | 0.44 | 0.46 |
Diluted Net EPS | NA | -0.81 | 0.28 | -0.44 | -0.02 |